logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-9. Opioid substitution treatment in prison in EU 27, Croatia, Turkey and Norway

CountryResponsibility for prison health with Min of HealthNotes on OST introduction, initiation and continuationIntroduction of OST in prison SourceInitiation of OSTContinuation of OSTSourceTotal number of prisoners on a given daySourceNumber of prisoners in OSTSource% of prison population in OST Notes on OST rate
Belgiumno2000 15YesYes11001211303113.03(xiv)
Bulgariano(i)(2008)2NoYes11072336120.20(xvii)
Czech Republicno(ii)20072YesYes12050232120.10
Denmarkno1988 15YesYes134513450213.04(x)
Germanyno199018Yes Yes174706365020.59(xviii)
Estoniano20082NoYes 136563220.05(ix)
Irelandno2000 15YesYes133342509215.27(xi)
GreecenoOST not availableNoNo1117983020
Spainno(iii) 199815YesYes1634701374312, 1311.71
Franceyes19962YesYes1667123:8.90(xxiii)
Italyyes 2000 15YesYes1558313434327.78(xxiv)
Cyprusno(iv)OST not available2NoNo18313020
LatvianoOST not available2NoNo164523020
Lithuaniano(v)OST not available2(Yes)(Yes)178423020
Luxembourgno200019YesYes110302216220.97
Hungaryno(vi)20052(Yes)(Yes)1150793120.005(xviv)
Maltano:NoYes15773::
Netherlandsno19852YesYes111934760075(xi)
Austriano1991 16YesYes188871277228.69(xii)
Polandno(vii)200615NoYes18315236020.06(xx)
Portugalno1999 15YesYes110807366426.14
Romaniano20082YesYes12726231820.17(xxi)
Sloveniano1995 15YesYes113296172612.94
SlovakianoOST not availablenoNo183133020
Finlandno19962NoYes1353135051.42
Swedenyes200620YesYes2685335 to 4080.33(xv)
UK England and Wales yes200621YesYes1831943:15.53(xxii)
UK N Irelandno:NoYes1015233::
UK Scotlandplanned2003 15YesYes1712621354219.00(xiii)
Croatiano:YesYes1447343:4.10(xvi)
TurkeynoOST not availableNoNo1994163020
Norwayyes(viii)200217(Yes)Yes13278316745.09

Notes:

 Where data are not available for a country, the table entry is left empty. 

 Data on the number of prisoners receiving OST refer to a given day in 2008, if not indicated otherwise.                                

 Notes on OST introduction, initiation and continuation in prison:                               

 (i) Not fully introduced, but continuation of the treatment if it was started outside prison became possible in 2008.                               

 (ii) OST was officially introduced in custodial settings in 2003 but only started in 2007.                                

 (iii) OST was developed as part of a harm reduction strategy in 1992 and was extended to all prisons in 1998. Data do not include Catalonia.                               

 (iv) Foreseen in Cyprus Action Plan by 2012.                               

 (v) Currently no OST is provided in prisons in Lithuania.                               

 (vi) The treatment has to be provided daily at external treatment centers.                               

 (vii) A first pilot of OST in custodial settings was conducted in 2003.                               

 (viii) Initiation of OST has to be carried out by na external regional maintenance treatment provider.                               

 Notes on OST rate:                               

 (ix) Rate based on yearly number of treatments.                               

 (x) Rate based on average monthly number of treatments.                               

 (xi) Rate refers to situation on 31.12.2009.                               

 (xii) Rate refers to situation on 1.9.2007.                               

 (xiii) Rate refers to situation on 14.12.2007.                               

 (xiv) Rate refers to situation on 27.1.2009.                               

 (xv) Reported daily rate is midpoint between high and low estimates of two studies, estimating the number of prisoners receiving OST on a given day in 2008 (see German National Report 2009). Pfeiffer-Gerschel et al. 2009, estimated 500 to 700 cases and Keppler (2008) estimated between 600 and 800 cases. Resulting rates are 0.07% and 0.59% respectively.   

 (xvi) Rate based on yearly number of treatments (N=721) and total number of entries to penal institutions (14.537 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xvii) Rate based on yearly number of treatments (N=61) and total number of entries to penal institutions (30.676 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xviii) Rate based on yearly number of treatments (N=650) and total number of entries to penal institutions (109.996 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xviv) Rate based on yearly number of treatments (N=1) and total number of entries to penal institutions (20.431 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xx) Rate based on yearly number of treatments (N=60) and total number of entries to penal institutions (94.940 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xxi) Rate based on yearly number of treatments (N=18) and total number of entries to penal institutions (10.865 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xxii) Rate based on 19.550 extended substitution treatments in 2008/9 (UK NR 2009) and total number of entries to penal institutions in 2008 (125.881 prisoners, CoE SPACE I Survey 2008, Table 12.1).                               

 (xxiii) Results of a nationwide inventory of harm reduction measures in French prisons, conducted in 2009/2010 among 105 prisons, covering 71,3% of inmates, unpublished. Personal communication, Laurent Michel, 10 May 2010.    

 (xxiv) Included are 2609 prisoners in medium- and 1734 prisoners in longterm-methadone treatment on a given day in 2008.   

Sources:

 (1) Structured Questionnaire on 'prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted by NFPs in 2008. 

 (2) Reitox National Reports. 

 (3) CoE SPACE I Survey 2008, Table 1: Total number of prisoners including pre-trial detainees on 1.9.2008. 

 (4) Personal communication Odd Hordvin, Norwegian NFP 1 March 2010                               

 (5) Personal communication Anu Mäenpää, Criminal Sanctions Agency Finland, 7 March 2010.                               

 (6) Personal communication Andrej Kastelic, 16 March 2010                               

 (7) Personal communication Gerda van't Hoff 16 March 2010 - based on reply by the Netherlands to a survey among Health in Prison Network Members in January 2010.                               

 (8) Personal communication Kajsa Mikkelson, Swedish NFP, 23 March 2010.                               

 (9) Personal communication Laurent Michel, 12 April 2010.                               

 (10) Personal communication Alan Lodwick, UK NFP, 12 March 2010.                               

 (11) Personal communication Bahija Lamkaddem, Belgian NFP, 19 February 2010.                               

 (12) CoE SPACE I Survey 2007, Table 1: Total number of prisoners including pre-trial detainees on 1.9.2007.                               

 (13) Based on reply by Spain to survey among Health in Prison Network Members in January 2010.                               

 (14) Personal communication Lidia Vulkovich, 2009.                               

 (15) H. Stover, L.C. Hennebel, J. Casselman "Substitution treatment in European prisons. A study of policies of substitution in prisons in 18 European countries", Cranstoun Drug Services Publishing 2004                               

 (16) H. Stover, "Study On Assistance To Drug Users in Prisons", EMCDDA 2001.                               

 (17) Personal communication Odd Hordvin, 13 April 2010.                               

 (18) Gerlach, R. & Stöver, H. (2005). Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland – Zwischenbilanz und Aufgaben für die Zukunft. Lambertus-Verlag: Freiburg.                               

 (19) Personal communication Origer Alain, Luxembourg NFP 16 April 2010.                               

 (20) Personal communication Kajsa Mikkelson, Swedish NFP, 21 April 2010.                               

 (21) Personal communication Charlotte Davies, UK NFP, 20 May 2010.                               

(see the help page for information about formats etc.)

Page last updated: Wednesday, 05 January 2011